Bicarbonate

Bicarbonate

SCHEMBL6205907

O=C(O)O.c1ccc(OC2CCCCC2)cc1

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 1/20 0.55
PARP10 Q53GL7 1/20 0.53
ALDH1A1 P00352 1/20 0.50
RAB9A P51151 1/20 0.50
EPHX2 P34913 4/20 0.49
FAAH O00519 1/20 0.48
KAT6A Q92794 1/20 0.48
SLC6A4 P31645 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
FFAR4 Q5NUL3 2/20 0.47
FFAR1 O14842 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL791816 0.92 HRH1 (0.63) HRH1PARP10ALDH1A1RAB9AEPHX2
SCHEMBL11792902 0.92 HRH1 (0.63) HRH1PARP10ALDH1A1RAB9AEPHX2
SCHEMBL1829827 0.89 HRH1 (0.65) HRH1PARP10ALDH1A1KAT6ASLC6A4
Phenol SCHEMBL28176906 0.86 HRH1 (0.53) HRH1PARP10ALDH1A1RAB9AEPHX2
SCHEMBL796490 0.85 HRH1 (0.65) HRH1PARP10SLC6A4SLC6A2SLC6A3
SCHEMBL11503151 0.84 HRH1 (0.55) HRH1PARP10ALDH1A1SLC6A4SLC6A2
SCHEMBL28310871 0.84 HRH1 (0.55) HRH1PARP10ALDH1A1EPHX2FAAH
Ammonia Solution, Strong SCHEMBL8081694 0.83 HRH1 (0.63) HRH1PARP10SLC6A4SLC6A2SLC6A3
Fluoride SCHEMBL28194548 0.83 HRH1 (0.63) HRH1PARP10SLC6A4SLC6A2SLC6A3
SCHEMBL1817555 0.81 EPHX2 (0.70) PARP10ALDH1A1RAB9AEPHX2FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1597228-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS Sanofi-Aventis Deutschland GmbH (DE) 2005-11-23 EP disclosed
WO-2004072025-A2 SUBSTITUTED N-ARYLHETEROCYCLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-08-26 WO disclosed